617 filings
Page 2 of 31
8-K
osw6vq7 473hl
28 Feb 23
TG Therapeutics Provides Business Update and Reports Fourth Quarter and Year-End 2022 Financial Results
7:33am
8-K
scju9
28 Dec 22
U.S. Commercial launch expected Q1 2023
4:30pm
8-K
99y5m2lcvommbtx2 ri
10 Nov 22
TG Therapeutics Provides Business Update and Reports Third Quarter 2022 Financial Results
7:38am
S-3ASR
1nzws8ve9b7 h5
2 Sep 22
Automatic shelf registration
4:31pm
8-K
7mkvq 82vizg8kr6o
8 Aug 22
TG Therapeutics Provides Business Update and Reports Second Quarter 2022 Financial Results
7:37am
S-8
t8iiaa d5orst
24 Jun 22
Registration of securities for employees
5:10pm
8-K
hcnyf7
23 Jun 22
Submission of Matters to a Vote of Security Holders
4:31pm
DEFA14A
7sdo8m6j6 n6g3flfgct
29 Apr 22
Additional proxy soliciting materials
12:00am
8-K
w56j0htyla ndxixm5
18 Apr 22
TG Therapeutics Announces Voluntary Withdrawal of the BLA/sNDA for U2 to Treat Patients with CLL and SLL
7:30am
8-K
a5tyo
1 Mar 22
TG Therapeutics Provides Business Update and Reports Fourth Quarter and Year-End 2021 Financial Results
8:15am
8-K
se93xxrf88zibmc1
27 Jan 22
Other Events
10:01am
8-K
qcufmgv
4 Jan 22
Entry into a Material Definitive Agreement
7:39am
8-K
h8ujike84c6uo jprwb
30 Nov 21
TG Therapeutics Provides Regulatory Update
7:59am
8-K
ympyq
4 Nov 21
TG Therapeutics Provides Business Update and Reports Third Quarter 2021 Financial Results
7:27am